While both SPHK1 and SPHK2 participate in the phosphorylation of sphingosine, the expression of SPHK1 is elevated in IDHwt glioma patients and is highly correlated with a worse prognosis compared to SPHK2 [39]. Here, SPHK1 is linked to central nervous system cancer.